Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Advanced Solid Tumor
- HER2 Positive Breast Cancer
- HER2 Positive Gastric Cancer
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Sequential AssignmentIntervention Model Description: Modified 3+3 DesignMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04450732
- Collaborators
- CRC Oncology
- Investigators
- Principal Investigator: Sarina Piha-Paul M.D. Anderson Cancer Center
Get Well Soon